High-throughput profiling for discovery of non-coding RNA biomarkers of lung disease

References

• Papers of special note have been highlighted as:
   Google Scholar
• • of interest
   Google Scholar
• •• of considerable interest
   Google Scholar
• International Human Genome Sequencing, C. Finishing the euchromatic sequence of the human genome. Nature. 2004;431:931–945.
   PubMed Web of Science ®Google Scholar
• Djebali S, Davis CA, Merkel A, et al. Landscape of transcription in human cells. Nature. 2012;489:101–108.
   PubMed Web of Science ®Google Scholar

•• This paper from the ENCODE project reports evidence that three-quarters of the human genome is capable of being transcribed and that genes are highly interlaced with overlapping transcripts that are synthesized from both DNA strands.

• Rana TM. Illuminating the silence: understanding the structure and function of small RNAs. Nat Rev Mol Cell Biol. 2007;8:23–36.
   PubMed Web of Science ®Google Scholar
• Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75:843–854.
   PubMed Web of Science ®Google Scholar

• This paper is the first report of microRNA function, which was lin-4 and was initially discovered for its role in regulating developmental timing in nematodes.

• Lytle JR, Yario TA, Steitz JA. Target mRNAs are repressed as efficiently by microRNA-binding sites in the 5ʹ UTR as in the 3ʹ UTR. Proc Natl Acad Sci USA. 2007;104:9667–9672.
   PubMed Web of Science ®Google Scholar
• Hausser J, Syed AP, Bilen B, et al. Analysis of CDS-located miRNA target sites suggests that they can effectively inhibit translation. Genome Res. 2013;23:604–615.
   PubMed Web of Science ®Google Scholar
• Liu J. Control of protein synthesis and mRNA degradation by microRNAs. Curr Opin Cell Biol. 2008;20:214–221.
   PubMed Web of Science ®Google Scholar
• Brennecke J, Stark A, Russell RB, et al. Principles of MicroRNA–Target Recognition. PLoS Biol. 2005;3:e85.
   PubMed Web of Science ®Google Scholar

•• An excellent article examining and establishing some requirements for microRNA::target binding and specificity and provides an insight into the scope of miRNA control, providing evidence that an average miRNA has approximately 100 target sites.

• Booton R, Lindsay MA. Emerging role of microRNAs and long noncoding RNAs in respiratory disease. Chest. 2014;146:193–204.
   PubMed Web of Science ®Google Scholar
• Szafranski P, Dharmadhikari AV, Brosens E, et al. Small noncoding differentially methylated copy-number variants, including lncRNA genes, cause a lethal lung developmental disorder. Genome Res. 2013;23:23–33.
   PubMed Web of Science ®Google Scholar
• Williams AE, Moschos SA, Perry MM, et al. Maternally imprinted microRNAs are differentially expressed during mouse and human lung development. Dev Dyn. 2007;236:572–580.
   PubMed Web of Science ®Google Scholar
• Harris KS, Zhang Z, McManus MT, et al. Dicer function is essential for lung epithelium morphogenesis. Proc Natl Acad Sci USA. 2006;103:2208–2213.
   PubMed Web of Science ®Google Scholar
• Gilad S, Lithwick-Yanai G, Barshack I, et al. Classification of the four main types of lung cancer using a microRNA-based diagnostic assay. J Mol Diagn. 2012;14:510–517.
   PubMed Web of Science ®Google Scholar
• WHO. WHO | Burden of COPD [Internet]. 2013. [cited 2015 Jul 24]. Available from: http://www.who.int/respiratory/copd/burden/en/index.html
   Google Scholar
• Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease GOLD executive summary. Am J Respir Crit Care Med. 2013;187:347–365.
   PubMed Web of Science ®Google Scholar
• Akbas F, Coskunpinar E, Aynaci E, et al. Analysis of serum micro-RNAs as potential biomarker in chronic obstructive pulmonary disease. Exp Lung Res. 2012;38:286–294.
   PubMed Web of Science ®Google Scholar
• Soeda S, Ohyashiki JH, Ohtsuki K, et al. Clinical relevance of plasma miR-106b levels in patients with chronic obstructive pulmonary disease. Int J Mol Med. 2013;31:533–539.
   PubMed Web of Science ®Google Scholar
• Xie L, Wu M, Lin H, et al. An increased ratio of serum miR-21 to miR-181a levels is associated with the early pathogenic process of chronic obstructive pulmonary disease in asymptomatic heavy smokers. Mol Biosyst. 2014;10:1072–1081.
   PubMed Web of Science ®Google Scholar
• Comer BS, Ba M, Singer CA, et al. Epigenetic targets for novel therapies of lung diseases. Pharmacol Ther. 2015;147:91–110.
   PubMed Web of Science ®Google Scholar
• Wenzel S. Severe asthma in adults. Am J Respir Crit Care Med. 2005;172:149–160.
   PubMed Web of Science ®Google Scholar
• Tsitsiou E, Williams AE, Moschos SA, et al. Transcriptome analysis shows activation of circulating CD8+ T cells in patients with severe asthma. J Allergy Clin Immunol. 2012;129:95–103.
   PubMed Web of Science ®Google Scholar
• Panganiban RPL, Pinkerton MH, Maru SY, et al. Differential microRNA epression in asthma and the role of miR-1248 in regulation of IL-5. Am J Clin Exp Immunol. 2012;1:154–165.
   PubMedGoogle Scholar
• Sinha A, Yadav AK, Chakraborty S, et al. Exosome-enclosed microRNAs in exhaled breath hold potential for biomarker discovery in patients with pulmonary diseases. J Allergy Clin Immunol. 2013;132:219–222.
   PubMed Web of Science ®Google Scholar
• Pinkerton M, Chinchilli V, Banta E, et al. Differential expression of microRNAs in exhaled breath condensates of patients with asthma, patients with chronic obstructive pulmonary disease, and healthy adults. J Allergy Clin Immunol. 2013;132:217–219.
   PubMed Web of Science ®Google Scholar
• Roff AN, Craig TJ, August A, et al. MicroRNA-570-3p regulates HuR and cytokine expression in airway epithelial cells. Am J Clin Exp Immunol. 2014;3:68–83.
   PubMedGoogle Scholar
• Sheridan MB, Hefferon TW, Wang N, et al. CFTR transcription defects in pancreatic sufficient cystic fibrosis patients with only one mutation in the coding region of CFTR. J Med Genet. 2011;48:235–241.
   PubMed Web of Science ®Google Scholar
• Oglesby IK, Bray IM, Chotirmall SH, et al. miR-126 is downregulated in cystic fibrosis airway epithelial cells and regulates TOM1 expression. J Immunol. 2010;184:1702–1709.
   PubMed Web of Science ®Google Scholar
• Ramachandran S, Karp PH, Osterhaus SR, et al. Post-transcriptional regulation of cystic fibrosis transmembrane conductance regulator expression and function by microRNAs. Am J Respir Cell Mol Biol. 2013;49:544–551.
   PubMed Web of Science ®Google Scholar
• Gillen AE, Gosalia N, Leir SH, et al. MicroRNA regulation of expression of the cystic fibrosis transmembrane conductance regulator gene. Biochem J. 2011;438:25–32.
   PubMed Web of Science ®Google Scholar
• Megiorni F, Cialfi S, Dominici C, et al. Synergistic post-transcriptional regulation of the cystic fibrosis transmembrane conductance regulator (CFTR) by miR-101 and miR-494 specific binding. PLoS One. 2011;6:e26601.
   PubMed Web of Science ®Google Scholar
• Hassan F, Nuovo GJ, Crawford M, et al. MiR-101 and miR-144 regulate the expression of the CFTR chloride channel in the lung. PLoS One. 2012;7:e50837.
   PubMed Web of Science ®Google Scholar
• Ramachandran S, Karp PH, Jiang P, et al. A microRNA network regulates expression and biosynthesis of wild-type and DeltaF508 mutant cystic fibrosis transmembrane conductance regulator. Proc Natl Acad Sci USA. 2012;109:13362–13367.
   PubMed Web of Science ®Google Scholar
• Oglesby IK, Chotirmall SH, McElvaney NG, et al. Regulation of cystic fibrosis transmembrane conductance regulator by microRNA-145, −223, and −494 is altered in DeltaF508 cystic fibrosis airway epithelium. J Immunol. 2013;190:3354–3362.
   PubMed Web of Science ®Google Scholar
• Fan Y, Zhou Y, Zhou X, et al. MicroRNA 224 regulates ion transporter expression in ameloblasts to coordinate enamel mineralization. Mol Cell Biol. 2015;35:2875–2890.
   PubMed Web of Science ®Google Scholar
• Viart V, Bergougnoux A, Bonini J, et al. Transcription factors and miRNAs that regulate fetal to adult CFTR expression change are new targets for cystic fibrosis. Eur Respir J. 2014. DOI:10.1183/09031936.00113214.
   PubMed Web of Science ®Google Scholar
• McKiernan PJ, Cunningham O, Greene CM, et al. Targeting miRNA-based medicines to cystic fibrosis airway epithelial cells using nanotechnology. Int J Nanomedicine. 2013;8:3907–3915.
   PubMed Web of Science ®Google Scholar
• Kumar P, Bhattacharyya S, Peters KW, et al. miR-16 rescues F508del-CFTR function in native cystic fibrosis epithelial cells. Gene Ther. 2015;1–9. DOI:10.1038/gt.2015.56.
   PubMed Web of Science ®Google Scholar
• Fabbri E, Borgatti M, Montagner G, et al. Expression of microRNA-93 and Interleukin-8 during Pseudomonas aeruginosa-mediated induction of proinflammatory responses. Am J Respir Cell Mol Biol. 2014;50:1144–1155.
   PubMed Web of Science ®Google Scholar
• Oglesby IK, Vencken SF, Agrawal R, et al. miR-17 overexpression in cystic fibrosis airway epithelial cells decreases interleukin-8 production. Eur Respir J. 2015. DOI:10.1183/09031936.00163414.
   PubMed Web of Science ®Google Scholar
• Zhang P-X, Cheng J, Zou S, et al. Pharmacological modulation of the AKT/microRNA-199a-5p/CAV1 pathway ameliorates cystic fibrosis lung hyper-inflammation. Nat Commun. 2015;6:6221.
   PubMed Web of Science ®Google Scholar
• Pandit KV, Corcoran D, Yousef H, et al. Inhibition and role of let-7d in idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2010;182:220–229.
   PubMed Web of Science ®Google Scholar
• Liu G, Friggeri A, Yang Y, et al. miR-21 mediates fibrogenic activation of pulmonary fibroblasts and lung fibrosis. J Exp Med. 2010;207:1589–1597.
   PubMed Web of Science ®Google Scholar
• Cushing L, Kuang PP, Qian J, et al. miR-29 is a major regulator of genes associated with pulmonary fibrosis. Am J Respir Cell Mol Biol. 2011;45:287–294.
   PubMed Web of Science ®Google Scholar
• Lino Cardenas CL, Henaoui IS, Courcot E, et al. miR-199a-5p is upregulated during fibrogenic response to tissue injury and mediates TGFbeta-induced lung fibroblast activation by targeting caveolin-1. PLoS Genet. 2013;9:e1003291.
   PubMed Web of Science ®Google Scholar
• Huang C, Yang Y, Liu L. Interaction of long non-coding RNAs and microRNAs in the pathogenesis of idiopathic pulmonary fibrosis. Physiol Genomics Physiolgenomics. 2015. 10.1152/physiolgenomics.00064.2015. 00064.2015
   Google Scholar
• Yang G, Yang L, Wang W, et al. Discovery and validation of extracellular/circulating microRNAs during idiopathic pulmonary fibrosis disease progression. Gene. 2015;562:138–144.
   PubMed Web of Science ®Google Scholar
• Li P, Li J, Chen T, et al. Expression analysis of serum microRNAs in idiopathic pulmonary fibrosis. Int J Mol Med. 2014;33:1554–1562.
   PubMed Web of Science ®Google Scholar
• Thai P, Statt S, Chen CH, et al. Characterization of a novel long noncoding RNA, SCAL1, induced by cigarette smoke and elevated in lung cancer cell lines. Am J Respir Cell Mol Biol. 2013. Available from: http://www.atsjournals.org/doi/abs/10.1165/rcmb.2013-0159RC#.VcpMMflVjM0
   PubMed Web of Science ®Google Scholar
• De Smet EG, Mestdagh P, Vandesompele J, et al. Non-coding RNAs in the pathogenesis of COPD. Thorax. 2015;70:782–791.
   PubMed Web of Science ®Google Scholar
• Bi H, Zhou J, Wu D, et al. Microarray analysis of long non-coding RNAs in COPD lung tissue. Inflamm Res. 2015;64:119–126.
   PubMed Web of Science ®Google Scholar
• Perry MM, Tsitsiou E, Austin PJ, et al. Role of non-coding RNAs in maintaining primary airway smooth muscle cells. Respir Res. 2014;15:58.
   PubMed Web of Science ®Google Scholar
• McKiernan PJ, Molloy K, Cryan SA, et al. Long noncoding RNA are aberrantly expressed in vivo in the cystic fibrosis bronchial epithelium. Int J Biochem Cell Biol. 2014;52:184–191.
   PubMed Web of Science ®Google Scholar
• Van Rooij E. The art of microRNA research. Circ Res. 2011;108:219–234.
   PubMed Web of Science ®Google Scholar
• Lopez JP, Diallo A, Cruceanu C, et al. Biomarker discovery: quantification of microRNAs and other small non-coding RNAs using next generation sequencing. BMC Med Genomics. 2015;8:35.
   PubMed Web of Science ®Google Scholar
• Griffiths-Jones S. The microRNA Registry. Nucleic Acids Res. 2004;32:D109–11.
   PubMed Web of Science ®Google Scholar
• Perdomo C, Campbell J, Schembri F. Detecting noncoding RNA expression: from arrays to next-generation sequencing. In: Fabbri M, editor. Non-coding RNAs and cancer. New York (NY): Springer; 2015. p. 25–44. DOI:10.1007/978-1-4614-8444-8_3.
   Google Scholar
• Guerau-de-Arellano M, Alder H, Ozer HG, et al. miRNA profiling for biomarker discovery in multiple sclerosis: from microarray to deep sequencing. J Neuroimmunol. 2012;248:32–39.
   PubMed Web of Science ®Google Scholar
• Castoldi M, Schmidt S, Benes V, et al. A sensitive array for microRNA expression profiling (miChip) based on locked nucleic acids (LNA). RNA. 2006;12:913–920.
   PubMed Web of Science ®Google Scholar
• Git A, Dvinge H, Salmon-Divon M, et al. Systematic comparison of microarray profiling, real-time PCR, and next-generation sequencing technologies for measuring differential microRNA expression. RNA. 2010;16:991–1006.
   PubMed Web of Science ®Google Scholar
• Geiss GK, Bumgarner RE, Birditt B, et al Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat Biotechnol. 2008;26:317–325.
   PubMed Web of Science ®Google Scholar
• Moldovan L, Batte KE, Trgovcich J, et al. Methodological challenges in utilizing miRNAs as circulating biomarkers. J Cell Mol Med. 2014;18:371–390.
   PubMed Web of Science ®Google Scholar

• This article reviews methological considerations for miRNA biomarker studies, but these considerations can also be applied to other ncRNA types.

• Farr RJ, Januszewski AS, Joglekar MV, et al. A comparative analysis of high-throughput platforms for validation of a circulating microRNA signature in diabetic retinopathy. Sci Rep. 2015;5:10375.
   PubMed Web of Science ®Google Scholar
• Wang Z, Gerstein M, Snyder M. RNA-Seq: a revolutionary tool for transcriptomics. Nat Rev Genet. 2009;10:57–63.
   PubMed Web of Science ®Google Scholar
• Metzker ML. Sequencing technologies - the next generation. Nat Rev Genet. 2010;11:31–46.
   PubMed Web of Science ®Google Scholar
• McHale CM, Zhang L, Thomas R, et al. Analysis of the transcriptome in molecular epidemiology studies. Environ Mol Mutagen. 2013;54:500–517.
   PubMed Web of Science ®Google Scholar
• Cui P, Lin Q, Ding F, et al. A comparison between ribo-minus RNA-sequencing and polyA-selected RNA-sequencing. Genomics. 2010;96:259–265.
   PubMed Web of Science ®Google Scholar
• Huang R, Jaritz M, Guenzl P, et al. An RNA-Seq strategy to detect the complete coding and non-coding transcriptome including full-length imprinted macro ncRNAs. PLoS One. 2011;6:e27288.
   PubMed Web of Science ®Google Scholar
• Cheng J, Kapranov P, Drenkow J, et al. Transcriptional maps of 10 human chromosomes at 5-nucleotide resolution. Science. 2005;308:1149–1154.
   PubMed Web of Science ®Google Scholar
• Du Z, Fei T, Verhaak RGW, et al. Integrative genomic analyses reveal clinically relevant long noncoding RNAs in human cancer. Nat Struct Mol Biol. 2013;20:908–913.
   PubMed Web of Science ®Google Scholar
• Mestdagh P, Hartmann N, Baeriswyl L, et al. Evaluation of quantitative miRNA expression platforms in the microRNA quality control (miRQC) study. Nat Methods. 2014;11:809–815.
   PubMed Web of Science ®Google Scholar
• Battich N, Stoeger T, Pelkmans L. Image-based transcriptomics in thousands of single human cells at single-molecule resolution. Nat Methods. 2013;10:1127–1133.
   PubMed Web of Science ®Google Scholar
• Pritchard CC, Cheng HH, Tewari M. MicroRNA profiling: approaches and considerations. Nat Rev Genet. 2012;13:358–369.
   PubMed Web of Science ®Google Scholar

•• An excellent thorough review of factors to be considered when profiling the expression of microRNA across various platforms.

• Peltier HJ, Latham GJ. Normalization of microRNA expression levels in quantitative RT-PCR assays: Identification of suitable reference RNA targets in normal and cancerous human solid tissues. Rna. 2008;14:844–852.
   PubMed Web of Science ®Google Scholar
• Mestdagh P, Van Vlierberghe P, De Weer A, et al. A novel and universal method for microRNA RT-qPCR data normalization. Genome Biol. 2009;10:R64.
   PubMed Web of Science ®Google Scholar
• Wylie D, Shelton J, Choudhary A, et al. A novel mean-centering method for normalizing microRNA expression from high-throughput RT-qPCR data. BMC Res Notes. 2011;4:555.
   PubMedGoogle Scholar
• Meyer SU, Pfaffl MW, Ulbrich SE. Normalization strategies for microRNA profiling experiments: a ‘normal’ way to a hidden layer of complexity? Biotechnol Lett. 2010;32:1777–1788.
   PubMed Web of Science ®Google Scholar
• Risso D, Ngai J, Speed TP, et al. Normalization of RNA-seq data using factor analysis of control genes or samples. Nat Biotechnol. 2014;32:896–902.
   PubMed Web of Science ®Google Scholar
• Weber JA, Baxter DH, Zhang S, et al. The microRNA spectrum in 12 body fluids. Clin Chem. 2010;56:1733–1741.
   PubMed Web of Science ®Google Scholar
• Huang W, Hu J, Yang D, et al. Two microRNA panels to discriminate three subtypes of lung carcinoma in bronchial brushing specimens. Am J Respir Crit Care Med. 2012;186:1160–1167.
   PubMed Web of Science ®Google Scholar
• Levänen B, Bhakta NR, Torregrosa Paredes P, et al. Altered microRNA profiles in bronchoalveolar lavage fluid exosomes in asthmatic patients. J Allergy Clin Immunol. 2013;131:894–903.
   PubMed Web of Science ®Google Scholar
• Tufman A, Gamarra F, Kiefl R, et al. Feasibility of microRNA measurements in routine bronchoalveolar lavage (BAL) and bronchial washings in patients with lung cancer and nonmalignant pulmonary diseases. Chest. 2014;145:342A.
   Web of Science ®Google Scholar
• Sagel SD, Chmiel JF, Konstan MW. Sputum biomarkers of inflammation in cystic fibrosis lung disease. Proc Am Thorac Soc. 2007;4:406–417.
   PubMedGoogle Scholar
• Wang K, Yuan Y, Cho J-H, et al. Comparing the MicroRNA spectrum between serum and plasma. PLoS One. 2012;7:e41561.
   PubMed Web of Science ®Google Scholar
• Willems M, Moshage H, Nevens F, et al. Plasma collected from heparinized blood is not suitable for HCV-RNA detection by conventional RT-PCR assay. J Virol Methods. 1993;42:127–130.
   PubMed Web of Science ®Google Scholar
• Al-Soud WA, Rådström P. Purification and characterization of PCR-inhibitory components in blood cells. J Clin Microbiol. 2001;39:485–493.
   PubMed Web of Science ®Google Scholar
• Garcia ME, Blanco JL, Caballero J, et al. Anticoagulants interfere with PCR used to diagnose invasive aspergillosis. J Clin Microbiol. 2002;40:1567–1568.
   PubMed Web of Science ®Google Scholar
• Kroh EM, Parkin RK, Mitchell PS, et al. Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR). Methods. 2010;50:298–301.
   PubMed Web of Science ®Google Scholar
• Witwer KW, Buzás EI, Bemis LT, et al. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J Extracell Vesicles. 2013;2:20360.
   PubMedGoogle Scholar
• Blondal T, Jensby Nielsen S, Baker A, et al. Assessing sample and miRNA profile quality in serum and plasma or other biofluids. Methods. 2013;59:S1–S6.
   PubMed Web of Science ®Google Scholar
• Arroyo JD, Chevillet JR, Kroh EM, et al. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S. 2011;108:5003–5008.
   PubMed Web of Science ®Google Scholar
• Vickers KC, Palmisano BT, Shoucri BM, et al. MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol. 2011;13:423–433.
   PubMed Web of Science ®Google Scholar
• Mitchell PS, Parkin RK, Kroh EM, et al. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA. 2008;105:10513–10518.
   PubMed Web of Science ®Google Scholar

• This article provides key evidence for the stability of endogenous microRNAs in blood and its fraction and therefore their usefulness as circulating, noninvasive biomarkers of disease.

• Ismail N, Wang Y, Dakhlallah D, et al. Macrophage microvesicles induce macrophage differentiation and miR-223 transfer. Blood. 2013;121:984–995.
   PubMed Web of Science ®Google Scholar
• Glasel JA. Validity of nucleic acid purities monitored by 260nm/280nm absorbance ratios. Biotechniques. 1995;18:62–63.
   PubMed Web of Science ®Google Scholar
• Meiri E, Mueller WC, Rosenwald S, et al. A second-generation microRNA-based assay for diagnosing tumor tissue origin. Oncologist. 2012;17:801–812.
   PubMed Web of Science ®Google Scholar
• Benjamin H, Lebanony D, Rosenwald S, et al. A diagnostic assay based on microRNA expression accurately identifies malignant pleural mesothelioma. J Mol Diagn. 2010;12:771–779.
   PubMed Web of Science ®Google Scholar
• van Gils MPMQ, Hessels D, van Hooij O, et al. The time-resolved fluorescence-based PCA3 test on urinary sediments after digital rectal examination; a Dutch multicenter validation of the diagnostic performance. Clin Cancer Res. 2007;13:939–943.
   PubMed Web of Science ®Google Scholar

• A very interesting study of the diagnostic performance of the FDA-approved urinary test for the lncRNA PCA3 for the diagnosis of prostate cancer.